Animal Health & Welfare (PHAW)*
Partnership website: https://www.pahealthwellness.com/
The partnership aims to deliver key knowledge, services and products to significantly improve the control of animal infectious diseases and animal welfare in a coordinated way which will sustain animal production and protect public health. It will involve reference laboratories, funding agencies and cooperate with the private sector.
By 2030, programmes will be further aligned, the animal health and welfare research and innovation ecosystem will be stronger, improving preparedness and providing additional solutions to prevent, detect and respond to priority infectious animal diseases, fight antimicrobial resistance, and improve animal welfare.
Final partnership proposal (April 2022)
Contact
Commission services: Jean-Charles Cavitte, Valerio Abbadessa
Partners: Sciensano, the Belgian Institute for Health - Hein Imberechts, Diagnostics For Animals - Jean-Louis Hunault
* Calls with opening dates in 2023-2024
What are partnerships?
Partnerships group the EC and private and/or public partners, to coordinate and streamline the research & innovation initiatives and funding in some selected key domains.
How to use partnerships?
-
orientation
Partnerships publish strategic documents, e.g. outlining the main research and innovation challenges or key focus points. -
networking
Partnerships often organise events, such as info days, brokerage events, etc. Meet potential partners and learn about the nuances that are not visible in the official documents. -
ecosystem analysis
Partnerships typically have an advisory board, and publish impact studies of previous actions. These are good sources of information to uncover the main R&D&I players in the domain. -
steering the agenda
Partnerships collaborate with the EC on outlining the strategy and the future funding opportunities in their domain, based on input from industry, academia, and other stakeholders.
Testimonial
SAPHIRe - Securing the Adoption of Personalised Medicin in Regions
The Department of Economy, Science and Innovation of the Flemish government coordinates the Horizon 2020 Coordination and Support Action SAPHIRe, which started on 1 December 2018. The aim of the project is to secure the adoption of personalised medicine in all European regions, including sparsely populated and remote regions and regions with different innovation capacities.
The activities of SAPHIRe are complementary to the smart specialisation partnership on personalised medicine – S3P4PM, which is also coordinated by the Department of Economy, Science and Innovation.
